Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXTW) Short Interest Update

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXTW) was the recipient of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 500 shares, an increase of 150.0% from the March 31st total of 200 shares. Based on an average trading volume of 3,000 shares, the days-to-cover ratio is currently 0.2 days.

Lixte Biotechnology Stock Performance

Shares of LIXTW remained flat at $0.05 during midday trading on Friday. The company has a fifty day moving average of $0.07 and a 200 day moving average of $0.07. Lixte Biotechnology has a 12-month low of $0.03 and a 12-month high of $0.14.

Lixte Biotechnology Company Profile

Lixte Biotechnology Holdings, Inc operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development.